Transient Pharma AB

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Alba Therapeutics Corp

This biopharmaceutical company develops oral peptide therapeutics to treat autoimmune and inflammatory conditions, such as celiac disease, for patients with gastrointestinal disorders.

Cinclus Pharma

This biopharmaceutical company develops small molecule drugs for patients suffering from gastric acid-related diseases, including erosive gastroesophageal reflux disease.

Aqilion

This biotech company develops early-stage drug treatments for chronic inflammatory diseases to supply pharmaceutical and biotechnology partners with new clinical development projects.

cAMPfield

The company develops oral biopharmaceutical medicines for patients with immune-mediated inflammatory diseases, specifically focusing on treatments for inflammatory bowel disease.

Aizen Therapeutics

This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.

CePep AB

This company develops cell-penetrating peptide delivery platforms for nucleic acid based therapeutics and drug discovery applications within the biotechnology and pharmaceutical industries.